All Pharma News
Chugai in-licenses RNAi therapeutic zilebesiran for hyp.high cardiovascular risk

Chugai in-licenses RNAi therapeutic zilebesiran for hyp.high cardiovascular risk
PHARMABIZ
20 Apr 2024
Share Share
Chugai Pharma announces Japanese phase III study of Vabysmo

Chugai Pharma announces Japanese phase III study of Vabysmo
PHARMABIZ
16 Apr 2024
Share Share
Chugai: Piasky (crovalimab) for Paroxysmal Nocturnal Hemoglobinuria approved in Japan

Chugai: Piasky (crovalimab) for Paroxysmal Nocturnal Hemoglobinuria approved in Japan
PRESS RELEASE
26 Mar 2024
Share Share
Roche autoimmune disease drug disappoints in closely watched trial

Roche autoimmune disease drug disappoints in closely watched trial
Jonathan Gardner BIOPHARMADIVE
22 Mar 2024
Share Share
Chugai’s Paroxysmal nocturnal hemoglobinuria drug bags first approval in China

Chugai’s Paroxysmal nocturnal hemoglobinuria drug bags first approval in China
BIOSPECTRUM ASIA
13 Feb 2024
Share Share
Chugai seeks Japanese approval for crovalimab to treat PNH

Chugai seeks Japanese approval for crovalimab to treat PNH
PHARMABIZ
15 Jun 2023
Share Share
Chugai obtains Japanese approval for FoundationOne Liquid CDx Genomic Profile

Chugai obtains Japanese approval for FoundationOne Liquid CDx Genomic Profile
PHARMABIZ
27 May 2023
Share Share
Chugai and Biofourmis Enter into New Partnership Focused on Data-Driven Care

Chugai and Biofourmis Enter into New Partnership Focused on Data-Driven Care
PR NEWSWIRE
02 Mar 2023
Share Share
Chugai Pharma & Towa Pharma introduce Edirol tablet for osteoporosis treatment

Chugai Pharma & Towa Pharma introduce Edirol tablet for osteoporosis treatment
PHARMABIZ
10 Dec 2022
Share Share
Chugai Pharma completes its new research centre, Chugai LSP Yokohama

Chugai Pharma completes its new research centre, Chugai LSP Yokohama
PHARMABIZ
19 Oct 2022
Share Share